EMA perspective on the value of model‐informed drug development for labeling recommendations regarding medicine use during pregnancy and breastfeeding
Year: 2024
Type: article
Abstract: shown on this cover page is limited to 10 maximum.
DOI: 10.1002/psp4.13214
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,940
OpenAlex ID: W4401536107
